(Q34404769)

2 August 2017

0 references

The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

3

Edzard Ernst

1 reference

2 August 2017

Igho Onakpoya

1

1 reference

PubMed ID

24533610

2 August 2017

Paul Posadzki

series ordinal

2

1 reference

2 August 2017

1 January 2014

1 reference

Journal of the American College of Nutrition

2 August 2017

1 reference

2 August 2017

33

1 reference

2 August 2017

1

1 reference

2 August 2017

70-78

1 reference

Obesity: Genetic, molecular, and environmental aspects

2 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Konjac acts as a natural laxative by increasing stool bulk and improving colonic ecology in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Evaluation of the pharmacotherapeutic efficacy of Garcinia cambogia plus Amorphophallus konjac for the treatment of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Sample size calculations for randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Statistical considerations in the intent-to-treat principle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

What is meant by intention to treat analysis? Survey of published randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Lifestyle modification for the management of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

Is funding source related to study reporting quality in obesity or nutrition randomized control trials in top-tier medical journals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07315724.2014.870013

10.1080/07315724.2014.870013

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

24533610